4ntj
From Proteopedia
(Difference between revisions)
(5 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
+ | |||
==Structure of the human P2Y12 receptor in complex with an antithrombotic drug== | ==Structure of the human P2Y12 receptor in complex with an antithrombotic drug== | ||
- | <StructureSection load='4ntj' size='340' side='right' caption='[[4ntj]], [[Resolution|resolution]] 2.62Å' scene=''> | + | <StructureSection load='4ntj' size='340' side='right'caption='[[4ntj]], [[Resolution|resolution]] 2.62Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4ntj]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4ntj]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] and [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4NTJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4NTJ FirstGlance]. <br> |
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=AZJ:ETHYL+6-{4-[(BENZYLSULFONYL)CARBAMOYL]PIPERIDIN-1-YL}-5-CYANO-2-METHYLPYRIDINE-3-CARBOXYLATE'>AZJ</scene>, <scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.62Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=AZJ:ETHYL+6-{4-[(BENZYLSULFONYL)CARBAMOYL]PIPERIDIN-1-YL}-5-CYANO-2-METHYLPYRIDINE-3-CARBOXYLATE'>AZJ</scene>, <scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene></td></tr> | |
- | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ntj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ntj OCA], [https://pdbe.org/4ntj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ntj RCSB], [https://www.ebi.ac.uk/pdbsum/4ntj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ntj ProSAT]</span></td></tr> |
- | <table> | + | </table> |
== Disease == | == Disease == | ||
- | [ | + | [https://www.uniprot.org/uniprot/P2Y12_HUMAN P2Y12_HUMAN] Resistance to clopidogrel in myocardial infarction, cerebrovascular accident, oblitering arteriopathy of the lower limbs;P2Y12 defect. The disease is caused by mutations affecting the gene represented in this entry. |
== Function == | == Function == | ||
- | [[ | + | [https://www.uniprot.org/uniprot/C562_ECOLX C562_ECOLX] Electron-transport protein of unknown function.[https://www.uniprot.org/uniprot/P2Y12_HUMAN P2Y12_HUMAN] Receptor for ADP and ATP coupled to G-proteins that inhibit the adenylyl cyclase second messenger system. Not activated by UDP and UTP. Involved in platelet aggregation. |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 17: | Line 18: | ||
Structure of the human P2Y12 receptor in complex with an antithrombotic drug.,Zhang K, Zhang J, Gao ZG, Zhang D, Zhu L, Han GW, Moss SM, Paoletta S, Kiselev E, Lu W, Fenalti G, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q Nature. 2014 May 1;509(7498):115-8. doi: 10.1038/nature13083. Epub 2014 Mar 23. PMID:24670650<ref>PMID:24670650</ref> | Structure of the human P2Y12 receptor in complex with an antithrombotic drug.,Zhang K, Zhang J, Gao ZG, Zhang D, Zhu L, Han GW, Moss SM, Paoletta S, Kiselev E, Lu W, Fenalti G, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q Nature. 2014 May 1;509(7498):115-8. doi: 10.1038/nature13083. Epub 2014 Mar 23. PMID:24670650<ref>PMID:24670650</ref> | ||
- | From | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
</div> | </div> | ||
+ | <div class="pdbe-citations 4ntj" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Escherichia coli]] |
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Cherezov V]] |
- | [[Category: Gao | + | [[Category: Fenalti G]] |
- | [[Category: Han | + | [[Category: Gao Z-G]] |
- | [[Category: Jacobson | + | [[Category: Han GW]] |
- | [[Category: Jiang | + | [[Category: Jacobson KA]] |
- | [[Category: Katritch | + | [[Category: Jiang H]] |
- | [[Category: Kiselev | + | [[Category: Katritch V]] |
- | [[Category: Lu | + | [[Category: Kiselev E]] |
- | [[Category: Moss | + | [[Category: Lu W]] |
- | [[Category: Muller | + | [[Category: Moss SM]] |
- | [[Category: Paoletta | + | [[Category: Muller CE]] |
- | [[Category: Stevens | + | [[Category: Paoletta S]] |
- | [[Category: Wu | + | [[Category: Stevens RC]] |
- | [[Category: Yang | + | [[Category: Wu B]] |
- | [[Category: Zhang | + | [[Category: Yang H]] |
- | [[Category: Zhang | + | [[Category: Zhang D]] |
- | [[Category: Zhang | + | [[Category: Zhang J]] |
- | [[Category: Zhang | + | [[Category: Zhang K]] |
- | [[Category: Zhao | + | [[Category: Zhang W]] |
- | [[Category: Zhu | + | [[Category: Zhao Q]] |
- | + | [[Category: Zhu L]] | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Structure of the human P2Y12 receptor in complex with an antithrombotic drug
|
Categories: Escherichia coli | Homo sapiens | Large Structures | Cherezov V | Fenalti G | Gao Z-G | Han GW | Jacobson KA | Jiang H | Katritch V | Kiselev E | Lu W | Moss SM | Muller CE | Paoletta S | Stevens RC | Wu B | Yang H | Zhang D | Zhang J | Zhang K | Zhang W | Zhao Q | Zhu L